CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I/II Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients With Advanced Hematological Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00241358
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:32.976341+00:00
Published At: 2017-06-06T00:00:00+00:00
Record Updated At: 2017-06-06
Results Posted At: 2017-06-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Leukemia, Myeloid, Acute", "Leukemia, Myelogenous, Chronic", "Leukemia, Lymphoblastic, Acute", "Lymphocytic Leukemia, Chronic", "Myelodysplastic Syndromes", "Multiple Myeloma", "Lymphoma, Non-Hodgkin", "Hodgkin Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-06-06"
protocolSection.identificationModule.nctId: "NCT00241358"
protocolSection.identificationModule.officialTitle: "A Phase I/II Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients With Advanced Hematological Malignancies"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-06-06"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.